FGL1 and neoplasm: Tumor cells overexpress FGL1 and PD-L1, which, respectively, bind to LAG-3 and PD-1 on T cells, forming important signaling pathways (FGL1/LAG-3 and PD-1/PD-L1) that negatively regulate immune responses.